Koa Shoji Holdings Co.,Ltd. (9273.T)
JPY 611.0
(2.0%)
JPY 611.0
(2.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 32 Billion JPY | 12.43% |
| 2022 | 28.46 Billion JPY | 8.44% |
| 2021 | 26.24 Billion JPY | 5.83% |
| 2020 | 24.8 Billion JPY | 8.31% |
| 2019 | 22.9 Billion JPY | 3.69% |
| 2018 | 22.08 Billion JPY | 2.29% |
| 2017 | 21.59 Billion JPY | 12.64% |
| 2016 | 19.17 Billion JPY | 18.5% |
| 2015 | 16.17 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 28.65 Billion JPY | 0.67% |
| 2023 FY | 32 Billion JPY | 12.43% |
| 2023 Q2 | 29.64 Billion JPY | 3.45% |
| 2023 Q4 | 32 Billion JPY | 6.67% |
| 2023 Q3 | 30 Billion JPY | 1.21% |
| 2022 Q3 | 27.53 Billion JPY | -0.31% |
| 2022 Q2 | 27.62 Billion JPY | 5.24% |
| 2022 Q1 | 26.25 Billion JPY | 0.0% |
| 2022 FY | 28.46 Billion JPY | 8.44% |
| 2022 Q4 | 28.46 Billion JPY | 3.36% |
| 2021 Q3 | 25.37 Billion JPY | -1.41% |
| 2021 FY | 26.24 Billion JPY | 5.83% |
| 2021 Q1 | 24.62 Billion JPY | -0.73% |
| 2021 Q4 | 26.24 Billion JPY | 3.45% |
| 2021 Q2 | 25.73 Billion JPY | 4.52% |
| 2020 Q2 | 23.49 Billion JPY | 5.68% |
| 2020 FY | 24.8 Billion JPY | 8.31% |
| 2020 Q1 | 22.23 Billion JPY | -2.92% |
| 2020 Q4 | 24.8 Billion JPY | 4.42% |
| 2020 Q3 | 23.75 Billion JPY | 1.1% |
| 2019 Q3 | 21.87 Billion JPY | 1.99% |
| 2019 FY | 22.9 Billion JPY | 3.69% |
| 2019 Q1 | 20.29 Billion JPY | -8.11% |
| 2019 Q2 | 21.44 Billion JPY | 5.68% |
| 2019 Q4 | 22.9 Billion JPY | 4.69% |
| 2018 Q2 | 20.85 Billion JPY | 0.86% |
| 2018 FY | 22.08 Billion JPY | 2.29% |
| 2018 Q4 | 22.08 Billion JPY | 5.4% |
| 2018 Q3 | 20.95 Billion JPY | 0.49% |
| 2018 Q1 | 20.67 Billion JPY | -4.25% |
| 2017 Q3 | 20.53 Billion JPY | 0.0% |
| 2017 FY | 21.59 Billion JPY | 12.64% |
| 2017 Q4 | 21.59 Billion JPY | 5.17% |
| 2016 FY | 19.17 Billion JPY | 18.5% |
| 2015 FY | 16.17 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | 12.493% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.788% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 96.473% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 97.741% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -107.535% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 87.85% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 81.352% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 97.704% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -86.254% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 90.266% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 79.846% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | 58.143% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | 35.408% |
| Tsumura & Co. | 428.25 Billion JPY | 92.527% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 87.735% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 76.015% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 92.568% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | 62.495% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 78.74% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 81.988% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -112.708% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | 58.815% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -108.467% |
| MedRx Co., Ltd | 2.05 Billion JPY | -1459.65% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -68.902% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -1155.059% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -1479.724% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | 65.702% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 91.623% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -659.323% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 95.862% |